What's New in Research Funding

Molecular structuresPage last updated December 5, 2018

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates

 

December 5, 2018
 

  • AGE-WELL Core Research Program (2020-2025) Request for Proposals (RFP). AGE-WELL is Canada’s Technology and Aging Network. The pan-Canadian Network brings together researchers, non-profits, industry, government, care providers, older adults and caregivers to develop technology-based solutions to support healthy aging. As AGE-WELL completes its first five-year mandate (2015-2020), the Network is developing its plans and goals for its next iteration, specifically from 2020-2025. A key aspect of this planning process is the development of AGE-WELL’s next Core Research Program, which is a set of integrated, long-term research projects that are the cornerstone of the Network’s activities. Visit the RFP for the overview of their 8 challenge areas and complete details. AGE-WELL has partnered with Mitacs and MEDTEQ to provide additional funding as part of this RFP. Additional partners and collaborators may join this funding initiative over the coming months. The maximum investment per Core Research Project is $200,000 per year (commencing April 1, 2020) for a minimum of 3 to a maximum of 5 years, for a maximum of $1,000,000 per grant. Deadline for applications: January 4, 2019. Visit the UofT funding opportunity webpage.
    *UPDATE: The UofT internal deadline is December 18, 2018 to accommodate the University's year-end closure. (Draft MRAs to be submitted by the internal deadline)
     
  • Hong Kong University (HKU) - University of Toronto Call for Joint Research Proposals 2018HKU and UofT are contributing matching funds to support collaborative education and research initiatives through a joint call for proposals. To be eligible, a proposal must include team participants from both institutions. Up to two successful proposals will be funded. HKU will provide each approved project up to $100,000 HKD per year to support HKU applicants. U of T will provide each approved project up to $16,000 CAD per year to support U of T applicants. The duration of each project is 12 months. Funding is intended to support research-related mobility expenses, such as costs related to funding travel for the exchange of researchers (students, post-doctoral fellows, research associates and/or PIs) between the institutions. Further details here. Questions should be directed to joanne.chou@utoronto.ca. Deadline for proposals: January 31, 2019.
     
  • International Student Experience Fund (ISEF): Second Impact Grant Competition 2018-2019. The Office of the Vice-President & Provost and the Office of the Vice-President, International are pleased to announce a second Impact Grant competition for the International Student Experience Fund (ISEF) with a deadline of February 1, 2019. 
    Funding Streams: The ISEF supports two streams of activities; Seed ($5,000-$15,000 per year) and Impact ($15,000-$100,000 per year). This two-tiered system is intended to provide opportunities for projects that explore, implement, and scale-up promising practices at different stages of their development and implementation, and create a pathway for projects from their initial inception to their full potential. Both tiers of grants are intended to be completed within 1 to 3 years. Visit their website to read the 2018/19 Thematic Areas. Seed Grants ($5,000-$15,000 per year) can be submitted at any time.
     
  • Physician's Services Inc. (PSI) Foundation: Update/Enhancement to Areas of Non-Support and Resident Research Grants. PSI Foundation is pleased to announce the following enhancements:
    •    PSI is no longer has a separate Mental Health research funding stream offered through a Letter of Intent process. Clinician researchers in the area of mental health are more than welcome to apply to any of their funding opportunities listed on their website (e.g. New Investigator grant). 
    •    The maximum amount of funding per application for Resident Research grants has been raised from $20,000 to $30,000
    Revised funding guidelines are available on their website.
     
  • Mitacs Canadian Science Policy Fellowship - Call for ApplicationsThe Canadian Science Policy Fellowship is now accepting applications from prospective fellows interested in undertaking a 12-month policy position within a Canadian government host office. Eligible applicants must be:
    •    Faculty members at Canadian universities or PhD graduates
    •    Canadian citizens or permanent residents (Citizenship requirements may differ for individual host offices; this will be accommodated in the fellow and host matching process)
    •    Able to negotiate a leave of absence from their university or employer, as applicable
    The 2019 cohort of fellowships will begin September 2019. UofT Internal deadline: January 27, 2019; Sponsor deadline: February 3, 2019.
     
  • UPDATES to NSERC New Research Partnerships Program - Framework and Strategic Partnerships (SPG). Further to information shared with the community about NSERC’s mandate to consolidate its Research Partnerships Programs, NSERC has updated its Framework for the new Partnerships Program. The revised Framework has now been published and is available for review on the NSERC websiteMembers of the research community are invited to review the new Framework and provide their feedback to NSERC.  Individual stakeholders are welcome to reply to RPR@nserc-crsng.gc.ca until January 2, 2019.  We would like to gauge responses from the U of T community and kindly request that a copy of your comments be sent to the Innovations & Partnerships Office via  colin.swift@utoronto.ca. Read more.
     
  • Huntington Society of Canada: Clinical Fellowship Pilot Program 2018. The objective of this program is to increase interest and participation in HD-specific research activities and provide an opportunity for clinicians to pursue future work on HD research projects within Canada. The purpose of this post-residency training is to provide expertise in the diagnosis and management of Huntington disease. Clinical training is the largest component of this hands-on program (at least 80%) but could include an element of research or an HD-specific clinical trial. Amount: $60,000 for one year. Deadline for applications: December 31, 2018.
     
  • (NEW!) Cancer Research Institute: Lloyd J. Old STAR (Scientists TAking Risks) Program. This Program will provide long-term funding to mid-career scientists, providing them a degree of freedom and flexibility to pursue high-risk, high-reward research at the forefront of discovery and innovation. These new grants will not be tied to a specific research project, but rather will support outstanding researchers based on the quality and promise of their overall work. A successful candidate is one that will demonstrate confidence and curiosity to ask difficult immunological questions—forging new understandings and innovation that will drive the field forward. Candidates selected for this award are expected to be future “stars” in the field of cancer immunology. Candidates must hold a tenure-track faculty appointment as an assistant professor (minimum 3 years) or as an associate professor (maximum of 3 years). Amount: USD $1.25 million over five years. Deadline for applications: March 1, 2019.
     
  • Friedreich's Ataxia Research Alliance (FARA):
    • Keith Michael Andrus Cardiac Research Award. Proposals for this award should focus on advancing understanding and/or treatment of the cardiac involvement in FA. Upper amount: USD $150,000 per year for 1 or 2 years. Deadline for Letters of Intent: January 15, 2019.
    • General Research Grants. This Grant is open to qualified investigators proposing projects that fall within FARA Research Priorities. To view lay abstracts of recent FARA-funded General Research Grants, click here. Deadline for Letters of Intent: February 1, 2019.
       

November 28, 2018
 

  • Women's College Research Institute, Women's Xchange: $15K Challenge. The Women's Xchange is offering $15,000 in one-time one year (non-renewable) grants to support research projects that address women’s health issues at the local level. The $15K Challenge is a competitive grant process and only select projects are funded. First time applying for a research grant? Women’s Xchange can provide guidance throughout the application and research process. With access to a Scientific Lead and assistance in developing academic partnerships, applicants will be supported with regards to developing a research proposal and conducting a successful research study. Visit the RFP to view eligibility and further details. Deadline for Notice of Intent: December 7, 2018; Application deadline: January 8, 2019.
     
  • Canadian Blood Services: Blood Efficiency Accelerator Program. The objective of this program is to improve the efficient and appropriate utilization of blood products, while maintaining the safety of the blood system. To achieve this objective, the Program will support innovative research projects that seek new knowledge or accelerate the application of existing knowledge. Maximum amount: $30,000 for one year. Deadline for applications: January 15, 2019.
     
  • Parkinson Canada: Research Grants Program. Pilot Project Grants (including a Targeted Competition: Progressive Supranuclear Palsy (PSP)) / New Investigator Awards / Basic Research Fellowships / Clinical Research Fellowship / Clinical Movement Disorders Fellowships / Graduate Student Awards. Deadline for all applications: February 4, 2019.
     
  • The Kidney Foundation of Canada, Kidney Research Scientist Core Education and National Training (KRESCENT) Program: New Investigator Award. This award to individuals who have clearly demonstrated excellence during their pre-doctoral and post-doctoral training in kidney disease, provides salary support for up to three years of the faculty appointment at the rank of Assistant Professor or its equivalent at a Canadian University. The purpose of this award is to assist such an individual to become established as a fully independent investigator in the field of kidney disease. Preference may be given to candidates who have been awarded and successfully completed a KRESCENT program Post-Doctoral Fellowship or Allied Health Doctoral Scholarship. It is expected that 50% of the award will be contributed by the KRESCENT Program and 50% by the host institution. Deadline for applications: February 1, 2019.
     
  • Leukemia Research Foundation, Hollis Brownstein Research Grants Program: New Investigator Grants. The Foundation is unique in the level of support it provides to highly promising scientists in this absolutely critical research niche. Providing one year grants of USD $100,000 for one year to selected New Investigator researchers, allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs. New Investigators are considered to be within seven (7) years of their first independent position. Preference will be given to proposals that focus on leukemia, lymphoma, MDS, and multiple myeloma. Deadline for Letters of Intent: February 1, 2019.
     
  • Alex's Lemonade Stand Foundation. Pediatric Cancer Research Grants.
    • Young Investigator Grants. Demonstration of outstanding mentorship and demonstration of a career plan that shows commitment to pediatric cancer investigation are critical components of a successful application. Upper amount: USD $150,000 over three years. Application deadline: December 17, 2018.
    • Epidemiology Grants. These grants support investigators to pursuing research studies in human populations, using epidemiological approaches, in order to significantly contribute to the understanding of childhood cancers. Hypothesis-driven research may focus on risk factors, early detection, prevention, effectiveness and treatment outcomes. Upper amount: USD $100,000 over two years. Application deadline: December 17, 2018.
       
  • US Dept. of Defense, CDMRP: Amyotrophic Lateral Sclerosis Research Program (ALSRP). 
    • Therapeutic Development Award. This award supports research ranging from validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed studies are expected to be empirical in nature and product driven. Upper amount: USD $1,000,000 over two years. Deadline for pre-applications: March 22, 2019.
    • Therapeutic Idea Award. The award is designed to promote new ideas aimed at drug or treatment discovery that are still in the early stages of development. Projects that focus primarily on investigating the pathophysiology of ALS are not within the scope of this Funding Opportunity. Innovation and impact are important aspects of the Therapeutic Idea Award. Deadline for pre-applications: March 22, 2019.
       
  • NIH Various Opportunities. The National Institutes of Health has recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
  • National Psoriasis Foundation (NPF): Research Grants Program.
    • Discovery Grants. Discovery Grants fund researchers while they explore preliminary ideas and conduct proof-of-concept experiments. Applications related to all aspects of psoriatic disease are strongly encouraged, including basic science, translational research, technology, epidemiology, health services, and clinical research. Applicants may request up to USD $75,000 per year. Deadline for applications: January 19, 2018.
    • Translational Research Grants. Translational Research Grants fund research initiatives that focus on the rapid translation of basic scientific discoveries into clinical applications with a clear benefit for patients with psoriatic disease. Applicants may request up to USD $100,000 per year. Deadline for applications: January 19, 2018.
    • Psoriatic Arthritis Research Grant. In a collaborative effort, the Arthritis National Research Foundation (ANRF) and the National Psoriasis Foundation (NPF) are seeking grant applications that focus on studying psoriatic arthritis. Applicants may request up to USD $100,000 per year. Deadline for applications: January 19, 2018.
    • Psoriatic Arthritis Diagnostic Test Grant. Through this exciting new program, NPF is seeking applicants to submit grants that aim to develop a clinically applicable diagnostic test for psoriatic arthritis within five years. Awards are up to USD $100,000 in year 1 for proof-of-concept studies with the possibility of renewal at up to $300,000 annually in subsequent years (five years total). Deadline for LOIs: December 14, 2018.
    • Early Career Research Grants. The NPF is seeking grant applications from graduate students, postdoctoral researchers, and researchers at similar trainee-level positions interested in conducting projects focused on psoriatic disease. Deadline for applications: January 19, 2018.

November 21, 2018
 

  • Ontario Brain Institute: Growing Expertise in Evaluation and Knowledge Translation (GEEK) Program. The GEEK program provides funding, evaluation expertise, and support to community-based programs and services for people living with brain disorders. GEEK supports the sustainability, scale or spread of these programs, to improve the quality and quantity of evidence-based care in the community. The GEEK program will allocate up to $200,000 per year. Deadline for Letters of Intent: November 26, 2018.
     
  • REMINDER: EMHSeed: Call for Proposals: EMHSeed funding program seeks seeding innovative research partnerships between researchers in Engineering, in Medicine, and in the Toronto Academic Health Sciences Network (TAHSN). EMHSeed will fund new collaborative projects beginning as early as January 2019. Each project will bring together an Engineering coPI and a Medicine/TAHSN coPI. For additional details and eligibility requirements please refer to the Call for Proposals (attached). The annual budget for each EMHSeed project will be $60,000 CAD/year for a maximum of 2 years. This is the sum total of cash invested by the collaborating Faculties and units.  
    Applications are due by email to vdr@ecf.utoronto.ca by close of business November 27, 2018. Please include the word “XSeed” in the subject line. Complete submissions should include: 1) the completed Application Form (template attached), 2) Letters of support confirming financial contributions from partner Departments/Institutes, and 3) CV of co-PIs (e.g. CCV or NSERC Form 100).
    EMH Seed Call for Proposals
    EMH Seed Application Form
     
  • REMINDER: UofT Connaught Committee: Connaught New Researcher Awards. Up to $1,000,000 will be awarded in the 2018-19 academic year to help new tenure stream faculty members establish competitive research programs. Support for approximately 50 awards of up to $20,000 will be provided to the highest ranked proposals (No matching required). These awards are intended to establish a strong research program, thereby increasing the faculty member's competitiveness for external funding. Applications are to be made using the form available on the Connaught funding opportunities webpage and submitted electronically via MRA (My Research Applications) by December 3, 2018.  Applicants are encouraged to login well in advance of advance of the December 1st submission deadline to ensure that there are no problems with login credentials and to leave appropriate time for the routing and approval process. Full program details and application materials can be found on the Connaught website. Questions may be addressed to connaught.secretariat@utoronto.ca or 416-978-7118.
     
  • CIHR Transitions in Care (TiC) – Evaluation Grants. The purpose of this funding opportunity is to support the rigorous evaluation of implemented activities such as interventions, tools, practices, policies, technologies, programs and/or other solutions that address transitions in care challenges. The total amount available for this funding opportunity is $3,200,000, enough to fund approximately 16 grants. Application deadline: February 5, 2019.
     
  • Mitacs Elevate Winter 2018 - Call for Applications. Mitacs Elevate provides two years of postdoc funding valued at $60,000/year plus extensive customized professional development training ($7,500/year non-cash value). Over the two-year fellowship, Elevate fellows divide their time between their partner organization project and university-based research with their faculty supervisor. Applicants are strongly encouraged to file an Intent to Apply with Mitacs by January 23, 2019 (details here). UofT Internal deadline: January 31, 2019; Sponsor deadline: February 6, 2019.
     
  • Mitacs: The New Accelerate Industrial Postdoc - Call for Applications. The new Accelerate industrial postdoc provides up to 3 years of internship funding valued at $55,000/year for research with an eligible company or not-for-profit. This is a limited-time offering with a UofT Internal deadline: Jan 11, 2019; Sponsor deadline: Jan 18, 2019. 
     
  • NSERC Commercialization Grants: Idea to Innovation (I2I). Four times per year, NSERC accepts applications for its “Idea to Innovation” (I2I) program, for the purpose of accelerating pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses. UofT Internal deadline: Friday, December 14, 2018; Sponsor deadline: January 7, 2018.
     
  • The Banting & Best Diabetes Centre:  Postdoctoral Fellowships. The BBDC will be awarding a number of postdoctoral fellowships to candidates at the post-PhD or post-MD degree stages.  The one-year fellowships normally commencing on July 1, 2019 (and no later than September 1, 2019) are for full-time research training in diabetes.  To be eligible, the candidate's proposed supervisor must be conducting diabetes research and must hold a faculty appointment with the University of Toronto at the level of Assistant, Associate, or Full Professor.  The proposed supervisor must be employed by the University of Toronto or a University of Toronto-affiliated institution, and must be a registered member of the BBDC at the time of application submission. Deadline for applications: February 26, 2019 at 4pm.
     
  • National Multiple Sclerosis Society. The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation.
    • Pilot Research Grants: Funding is provided for one year to test innovative, cutting-edge ideas or untested methods, and to gather sufficient preliminary data to apply for longer-term funding. Value: $50,000 for one year. Deadline for pre-applications: January 7, 2019.
    • Research Grants: These grants support studies related to MS that may serve to advance the mission stopping MS restoring function and improving the quality of life, and preventing MS. Applicants submit a budget per year. Deadline for pre-applications: February 6, 2019.
       
  • Simons Foundation: Autism Research Initiative (SFARI) Research Award. The goal of the Research Award is to provide support for investigation of key unresolved research questions in autism, particularly those that connect genetic etiologies to brain function and behavior. Unlike the SFARI Pilot Award, the Research Award welcomes risk and novelty, but these are not required criteria for a proposal to be considered meritorious. Competitive applications will have preliminary data or other relevant groundwork that justifies substantial investment in the proposed topic. In some cases, projects may include those focusing on a central hypothesis where success depends on close collaboration between two or more labs. The maximum budget of a Research Award is USD $1,300,000, including 20 percent indirect costs, over a period of up to four (4) years. Deadline for applications: January 11, 2019.
     
  • Bill & Melinda Gates Foundation - Grand Challenges Explorations:  Application of Metagenomic Next Generation Sequencing to Detect and Identify Pathogens (Round 22). Recognizing barriers for adoption of next-generation sequencing in global health, the Bill & Melinda Gates Foundation has partnered with the Chan Zuckerberg Biohub and the Chan Zuckerberg Initiative to enable patients in low- and middle-resource settings to benefit from cutting-edge pathogen detection and discovery. This partnership will provide highly specialized training in biosample preparation and sequencing to technical staff from awardee global health centers. Trainees will learn to use the open-source, open-access IDseq software developed by CZ-Biohub for the global health community to upload and analyze patient sequencing data. Initial grants are USD $100,000. Successful projects are eligible to receive follow-on funding to a maximum of $1,000,000. Deadline for applications: December 5, 2018.
     
  • The Michael J. Fox Foundation (MJFF) for Parkinson's Research: Edmond J. Safra Fellowship in Movement Disorders. By funding academic centers to train new movement disorder clinician-researchers, this program aims to develop a network of highly trained specialists to be the next generation of leaders in Parkinson's research and clinical care. The program grants funding directly to academic centers, which then must identify and train a new movement disorder fellow over a two-year period. MJFF will award five two-year fellowships (USD $90,000 per fellow per year for two years). Deadline for applications: December 19, 2018.
     
  • International Waldenstrom's Macroglobulinemia Foundation (IWMF) and LLS: Research GrantsThe IWMF supports research to understand the biology of WM, with the goals of improving quality of life for WM patients, discovering new treatments, and ultimately, finding a cure. This Request for Proposals (RFP) is to help further knowledge in four key domains of Waldenstrom's macroglobulinemia (WM) research: Genomics and Epigenomics; Signaling; Immunology/Immunotherapy; and Bone Marrow/Tumor Microenvironment. Upper amount: USD $400,000 over two years. Deadline for applications: February 13, 2019.
     
  • Children's Tumor Foundation (CTF): Young Investigator Award (YIA). The YIA provides two-year funding, commensurate with the National Institutes of Health (NIH), to young scientists early in their careers, bringing them into the neurofibromatosis field and helping to establish them as independent investigators. The program has been a 'seeding mechanism' for researchers and their mentors, who could showcase their Foundation-funded research to secure larger grants. Applicant must be one of the following: 
    a. A postdoctoral fellow (MD, Ph.D. or equivalent advanced degree) but no more than 7 years past the completion of their first doctoral degree, or 
    b. A graduate student pursuing their MD, Ph.D. or equivalent advanced degree
    Maximum request amount varies with the applicant's level of training at time of application (Upper USD $108,000; Lower $32,000). The Foundation seeks and welcomes applications from all qualified individuals worldwide. Deadline for Letters of Intent: January 4, 2019; Full application deadline: March 1, 2019.
     
  • International Association for the Study of Lung Cancer (IASLC):
    • Fellowship and Young Investigator Awards. Funding for these awards provides for the training of research fellows and young investigators who wish to pursue a career in lung cancer diagnosis, treatment, or laboratory research as well as other aspects of the study of lung tumors. These awards are granted for one year with a stipend grant of USD $50,000. Deadline for applications: December 15, 2018.
    • John's Legacy Fellowship (NEW). The objective of the this award funding is to encourage early detection and screening of lung cancer to become a standard of care in annual physicals. Applications must be within the scope of these priorities to be considered. Amount: USD $50,000 for one year. Deadline for applications: December 15, 2018.

November 8, 2018
 

  • Ted Rogers Centre for Heart Research: Innovation Fund - Seed Grants. The Centre’s Innovation Fund will provide Seed Grants of up to $100,000/year (renewable for 1 additional year) to support innovative research projects directly aligned with its Mission. Eligible projects must represent bonafide collaboration with at least two of the three partner institutions (SickKids, UHN, UofT) and may encompass the full spectrum of biomedical research, from basic science discovery to clinical interventions to health services or population health research. Selection of successful applications will be heavily weighted to those with the potential to transform our understanding or approach to heart failure. Deadline for 3-page letters of intent: November 30, 2018 at 5pm. Selected applicants will be invited to submit a full application. 
     
  • REMINDER: Call for Internal NOIs for selection in the upcoming CFI Innovation Fund (IF). Please be reminded that the internal deadline for submission of Notices of Intent to the upcoming CFI Innovation Fund (IF) competition is November 30, 2018. Instructions for completing and submitting an NOI can be found herePlease note that the NOI is to be submitted to your departmental Chair/equivalent and subsequently go to the Vice-Dean/Principal for divisional endorsement prior to the November 30th deadline. We strongly encourage you to discuss any plans for an NOI with the head of your unit and/or division at the earliest opportunity. 
     
  • REMINDER: Special Call for Applications from UofT Faculty for Canada Research Chairs. Consistent with the University's commitment to excellence and equity and with federal priorities for the Canada Research Chair (CRC) program, a special call is now posted on the University’s institutional CRC EDI website. Through this call the U of T is inviting applications to the Canada Research Chair program from faculty who self-identify in one or more of four federally designated groups: women, visible minorities or persons of colour, persons with a disability or Indigenous people. The call is open to full-time faculty who hold an appointment as an Assistant, Associate or Full Professor in the tenured/tenure-stream, clinical or status-only categories at the University of Toronto. Those in the clinical or status-only categories must be employed by an affiliated institution or be individuals who have a firm offer of employment in one of these categories from the University or its affiliated institutions that takes effect by July 1, 2019.
     
    It is anticipated that the posting will result in the selection of up to 19 candidates to the program, most of whom are expected to be Tier 2 Canada Research Chairs for exceptional, emerging scholars. The deadline for applications is November 26, 2018.  Applications should include a two-page letter of interest describing qualifications and research plans for the position; and a curriculum vitae. Inquiries regarding this competition and completed applications may be directed to crc@utoronto.ca. Further information on this call can be found here.
     
  • Parkinson's Foundation.
    • Parkinson's Foundation Research Centers of Excellence. The goal is to provide funding for innovative team science at institutions working on a thematic area of Parkinson's disease. The Foundation is interested in proposals that tackle critical issues or problems that are impeding progress in the field of PD research. Preference will be given to applications which demonstrate cross-departmental or cross-institutional collaboration, bringing new approaches and perspectives to solving PD. Amount: USD $2M over four years. Deadline for Letters of Intent: December 17, 2018, full applications due April 1, 2019. 
    • Clinical Research Awards. The Foundation is sponsoring a research award intended to facilitate the development of clinician scientists. This Award is open to all clinician-scientists who are licensed to care for patients regardless of nationality or location. Amount: USD $200,000 over two years. Deadline for Letters of Intent: January 22, 2019; full applications due April 8, 2019.
    • Impact Awards. Projects should be "outside the box" with the goal of bringing new light to the biology of Parkinson's, or testing a truly novel therapeutic idea. Projects should be for the best ideas that are unlikely to be funded through more traditional funding mechanisms.  Amount: USD $150,000 for approximately one year. Salary support is permitted capped at $50,000. Deadline for Letters of Intent: Continuous.
       
  • Allen Foundation: Nutrition Research Grants. The connections between diet and health remain a basic and primary priority, and consideration has always been given to projects that benefit nutritional programs in the areas of education, training, and research. Visit here to read the Foundation's priorities. Deadline for proposals: January 15, 2019.
     

November 1, 2018
 

  • McLaughlin Centre - Accelerator Grants in Genomic Medicine 2019: Whole Genome Data and Genetic Risk Scores.
    The McLaughlin Centre is pleased to announce its ninth research funding competition. The competition will be based on invited grant applications passing an initial letter of intent stage. Both steps will go through committee peer-review adjudicated by the Director. Priority will be given to applications demonstrating promise for near-term deliverables, potential to seed larger grants, and those involving two or more institutions from the University of Toronto Faculties (and their Departments and Institutes) and the hospitals/research institutes fully affiliated with the University of Toronto (TAHSN). 
    The emphasis in this Call will be Whole Genome Data and Genetic Risk Scores:
    1.    The application of Whole Genome Sequencing for research, discovery and/or clinical genomics. Leveraged large-scale data generation projects are emphasized;
    2.    Building databases and computational tools to collect and analyze whole genome datasets for multi-disciplinary team studies. Small leveraged grants are emphasized;
    3.    Development of statistical and computational approaches used in genetic risk score analyses for research and disease prediction modeling. Team-based or linked training grants are emphasized.
    Deadline for Letters of Intent: December 7, 2018.
     
  • 2019 Medicine by Design New (and Continuing) Ideas Awards. These awards focus on seeding new ideas or continuing previously funded Medicine by Design projects that have strong potential to advance regenerative medicine research and translation. Special consideration will be given to proposals that feature: Synthetic Biology; Mathematical modelling; Emergent phenomena; and or integration of pathophysiological issues (e.g. inflammation, vascularization). Beyond these topics, Medicine by Design is interested in supporting clinician-led projects that address a specific clinical goal. Proposals are encouraged from investigators who are new to the regenerative medicine community or not leading other Medicine by Design projects. Proposals are also encouraged from those who plan to continue developing previously funded Medicine by Design projects. Amount: $100,000 per year for two years. Each project must have only one lead principal investigator, and no more than 2 co-investigators. All investigators must have a faculty appointment at the University of Toronto. Deadline for Expressions of Interest: November 26, 2018 at 5pm.
     
  • 2018 Anne and Max Tanenbaum Symposium: Brain Development in the Face of Adversity.
    Wednesday, November 14th from 8:15am - 12:15pm

    Women's College Hospital, Conference Centre Auditorium, 76 Grenville Street, Toronto.
    RSVP by November 7th to medicine.research@utoronto.ca
     
  • University of Toronto: INFORMATION SESSIONS:
  • Genome Canada: Genomic Applications Partnership Program (GAPP) - Round 14. 
    Precision Health Initiative - Rare Diseases: Clinical Implementation Projects.
     The GAPP funds public-private research collaborations focused on developing genomics-derived technologies that address opportunities and challenges identified by industry, government, not-for-profits or other "receptors" of genomics knowledge and tools. Please note that the GAPP is a rolling program, and is currently in Round 14. Applicants interested in applying to the GAPP Round 14 are encouraged to contact Shobha Ramsubir at Ontario Genomics. For more information on the application process, please visit the GAPP homepage or the UofT funding opportunity
    Draft EOI is due to RSO and Ontario Genomics on November 19, 2018. Final EOIs are due to RSO December 18th.
     
  • New Funding Opportunity - Branch Out Neurological Foundation. Branch Out accelerates tech solutions and non-pharmaceutical approaches to neurological disorders. Through their Grant Program, they fund top neuroscientists exploring alternative brain research. They fund research that fits into the rigorous NeuroCAM (Neuroscience + Complementary & Alternative Modalities) criteria. Please note that the 2019 MSc and PhD opportunities are not available to UofT applicants but are expected to be in the future. Currently available opportunities:
    • Undergraduate Grants: Research must be in the area of neuroCAM. Amount: Up to $8,000. Deadline for applications: January 25, 2019.
    • PI Seed Grants: Branch Out is offering a series of seed grants for neuroCAM research done in conjunction with the U of T. The details of this grant are still being finalized, but you can email  research@branchoutfoundation.com to express your interest and learn more about this opportunity. Amount: Up to $50,000.  Deadline for applications: February 2019.
       
  • The Lung Association: Ontario, Provincial Lung Association Grant Awards Program, and Ontario Thoracic Society (OTS): 2019-2020 Grant-In-Aid competition. The objective of the Grant-In-Aid (GIA) competition is to 1) support pulmonary research or development projects directly relevant to human respiratory health, and 2) offer grants for research operating costs including laboratory supplies, technicians, and equipment. The nominated Principal Investigator must be a member of the OTS or the Ontario Respiratory Care Society. Particular consideration will be given to requests from investigators who have received their first faculty appointment within the past seven years. Amount: $50,000 for one year. Registration deadline: November 16, 208; Application deadline: December 7, 2018.
     
  • The Lung Association - Ontario and Ontario Respiratory Care Society (ORCS): ORCS Research Grant. The objective of the ORCS Research Grant is to promote research regarding any field of acute or chronic lung disease. Research may include investigation of any phenomenon pertinent to illness assessment, management, or responses of the individual with a respiratory condition. Research may also be aimed at health promotion, education and prevention issues. Studies may use quantitative or qualitative methodologies. The Association has limited funds available, therefore, large operating grants are unlikely. Partial funding may be awarded. Deadline for applications: February 1, 2019.
     
  • CIHR Transitions in Care (TiC) Team Grants. The focus of this funding opportunity is to support inter-disciplinary teams that are poised and ready to address transition in care challenges to optimize patient outcomes. The grants will provide funds to implement, evaluate, spread, and scale pragmatic solutions to problems associated with transitions in care from a clinical, health care and/or health system perspective. Application deadline: January 24, 2019. Partner Linkage Tool: CIHR has launched an on-line linkage tool designed to assist researchers and other stakeholders in identifying and connecting with potential partners to develop their projects.
     
  • CIHR Pre-announcement: Sepsis Research Initiative. The purpose of the Sepsis Research Network  funding opportunity is to fund a single nationally coordinated research network with the goal of further understanding the causes and improving the prevention, detection and management of sepsis. The Network will bring together experts from different disciplines working collaboratively on a number of inter-related research projects under an integrated and unified program of research. The total amount available for this funding opportunity is $5,800,000, enough to fund approximately four (4) Letters of Intent and one (1) Full Network grant. Deadline for LOIs: Winter 2019.
     
  • Crohn's and Colitis Canada.
    • Grants-in-Aid of Research. This program supports research on inflammatory bowel disease (IBD). This research program helps advance prevention, treatments, health policy and, ultimately find cures. Grants support research projects with a defined objective, conducted by an investigator working alone or in collaboration with others. Grants are awarded for a maximum of three years, at maximum $125,000 per annum. Deadline for Notices of Intent: November 23, 2018; Application deadline: January 18, 2019.
    • Innovations in IBD Research. The intent of this grant to fund novel or innovative approaches to IBD research. It is intended to stimulate and support research which may not be encompassed within the boundaries of traditional medical research. Research proposals must conform to sound principles of research and may aim to collect pilot data for follow-on application(s). Our organization seeks mission relevance and excellence as well as innovation. Grants to a maximum of $50,000 for one year may be awarded. Deadline for applications: January 18, 2019.
       
  • National Multiple Sclerosis Society: Therapeutic Development Opportunities for Neuroprotection and Neuroregeneration in Multiple Sclerosis  (Commercial R&D Funding). The objective of this funding opportunity is to fund 1) drug development for therapies promoting neuroprotection and repair, and 2) new treatment strategies preventing neurodegeneration, and reversing neuronal damage where lost function can be restored. Approaches that impact demyelination, remyelination, neuroprotection, neural plasticity, and repair are considered appropriate for this RFP. Up to $300,000 will be provided and must be justified based on the scientific and development 
    work plan. View the RFP. Deadline for pre-applications: December 5, 2018.
     
  • Springer Nature Ltd.: Global Grants for Gut Health (New). The Global Grants for Gut Health is a competitive programme for investigator-initiated research into the human gut microbiota, supported by Yakult and Nature Research. They will consider proposals for one-year research projects - whether laboratory investigations or clinical studies -that advance understanding of the impact of the gut microbiota on human health. The programme will make a maximum of three awards per funding cycle, each of up to US$100,000. Research projects will be one year in duration. Deadline for applications: November 30, 2018.
     
  • Cooley's Anemia Foundation.
    • Support for Ongoing Clinical Research in Thalassemia. National and international applicants are invited to apply for grants to support ongoing clinical research projects in thalassemia. Ongoing clinical projects should address one or more of the following areas impacting patients with thalassemia, including but not limited to: cardiac issues and iron overload; fertility, pregnancy and family planning; quality of life, psycho-social impact and/or burden of disease. Amount: USD $50,000 annually with possibility of one-year renewal. Deadline for Letters of Intent: December 20, 2018.
    • Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award. National and international applicants to apply for grants to facilitate clinical trials in Cell and Gene Therapy to advance a cure for thalassemia. Both phase I (safety) and phase II (efficacy) trials are eligible for support. Amount: USD $75,000 annually with possibility of one-year renewal. Deadline for Letters of Intent: December 20, 2018.
       
  • American Brain Tumor Association.
    • Discovery Grants. These grants specifically encourage novel research by allowing researchers to conduct the early scientific studies needed to secure additional/future funding for their projects. Additionally, investigators from sciences outside traditional biological fields are encouraged to apply. These grants seeks projects focused on all brain tumor types, benign or malignant, primary or secondary (metastatic). Amount: USD $50,000 for one year. Deadline for Letters of Intent: November 14, 2018.
    • Research Collaboration Grants.  The research projects supported under this mechanism must be conducted by a team of two co-principal investigators (Co-PIs) from distinct institutions. The research project should be multi-disciplinary in that it incorporates multiple components such as basic, translational, clinical, and epidemiological research. Amount: USD $200,000 over two years. Deadline for Letters of Intent: November 14, 2018.
       
  • Pulmonary Fibrosis Foundation:
    • Albert Rose Established Investigator Awards. The awards support projects that offer a high likelihood of improving the understanding of pulmonary fibrosis (PF) in the following areas: basic science, translational research, clinical medicine/research, and social science/quality of life. Two USD $50,000 grants are awarded per cycle. Deadline for Letters of Intent: November 30, 2018.
    • I.M. Rosenzweig Junior Investigator Awards. Researchers who have completed their formal training within the past five years are eligible for this award. Two USD $50,000 grants are awarded per annual cycle. Deadline for Letters of Intent: November 30, 2018.
       
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     

October 17, 2018
 

  • EMHSeed: Call for Proposals: EMHSeed funding program seeks seeding innovative research partnerships between researchers in Engineering, in Medicine, and in the Toronto Academic Health Sciences Network (TAHSN). EMHSeed will fund new collaborative projects beginning as early as January 2019. Each project will bring together an Engineering coPI and a Medicine/TAHSN coPI. For additional details and eligibility requirements please refer to the Call for Proposals (attached). The annual budget for each EMHSeed project will be $60,000 CAD/year for a maximum of 2 years. This is the sum total of cash invested by the collaborating Faculties and units.  
    Applications are due by email to vdr@ecf.utoronto.ca by close of business November 27, 2018. Please include the word “XSeed” in the subject line. Complete submissions should include: 1) the completed Application Form (template attached), 2) Letters of support confirming financial contributions from partner Departments/Institutes, and 3) CV of co-PIs (e.g. CCV or NSERC Form 100).
    INFORMATION SESSION: Tuesday, November 6th in WB 215 (Wallberg Building -  180 College St.) from 1pm-2pm.
    EMH Seed Call for Proposals
    EMH Seed Application Form
     
  • Canadian Cancer Society. Deadline for full applications: January 15, 2019
    • Innovation Grants. The goal of this program is to support the development and testing of unconventional concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate new approaches to confront the challenges we face in defeating cancer. Value: Up to $100,000 per year and a maximum of $200,000 per grant.
    • Innovation to Impact Grants. The goal of the Innovation program is to support the development and testing of unconventional concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate new approaches to confront the challenges we face in defeating cancer. Value: Up to $150,000 per year for up to 3 years.
    • Travel Awards. A limited number of Travel Awards to PhD or MD/PhD students, and post-doctoral/medical/clinical fellows are available. Eligible expenses will not exceed $2,000.
       
  • Cancer Research Society: Operating Grants. The objective of the Operating Grant is to support fundamental, early translational, and environmental-cancer research on all types of cancer to contribute to the advancement of science aimed at preventing, detecting and treating this disease. Amount: $60,000 per year for two years. Deadline for Letters of Intent: December 4, 2018.
     
  • POGO Research Unit: Seed Funding. POGO offers annual seed funding grants of up to $15,000 to facilitate or support feasibilities studies, the development of preliminary data to enable applications to other granting agencies or self-contained studies. Deadline for registration form: October 31, 2018. The full application will be sent to applicants once they have registered. Full application deadline: December 15, 2018 at 4pm.
     
  • Varian Medical Systems: Artificial Intelligence (AI) in radiation oncology - Call for proposals. Varian Medical system seeks innovative research to develop new applications of AI in radiation oncology as well as techniques to build confidence in the clinical use of AI. All faculty with expertise in Artificial Intelligence (AI) are encouraged to apply. Applicants are not required to hold affiliations with a medical school or hospital. Faculty with a background in AI are encouraged to consider this opportunity. The RFP is best suited for investigators with a solid understanding of clinical needs in radiation oncology. Multi-disciplinary teams with combined technical and clinical expertise are encouraged, but not required. While there is no specified limit on requested funds, awards could range from $25,000 to $500,000. Read the full RFP to view topics of interest and submission guidelines. To request a grant application form or to submit any questions, please email: research.collaborations@varian.com
     
  • Mitacs-JSPS Summer Program: Call for Applications. The Mitacs-JSPS Summer Program, offered in partnership with the Japan Society for the Promotion of Science (JSPS) provides opportunities for graduate students and postdoctoral fellows in Canada to pursue collaborative research in Japan, allowing them to advance their own research while promoting scientific progress in both Japan and Canada. Mitacs is now accepting applications for the Mitacs-JSPS Summer Program, which supports researchers in Canada to undertake 10-week research projects in Japan in Summer 2019. The program is open to graduate students and postdoctoral fellows in all disciplines at Canadian universities. UofT internal deadline: November 28, 2018; Sponsor deadline: December 5, 2018.
     
  • JDRF Innovative Grants. Innovative grants provide one year of support for a maximum of USD $100,000 in direct costs and indirect costs of 10%, for a total of USD $110,000. Deadline for proposals: October 31, 2018.
  • Burroughs Wellcome Fund (BWF) - Physician Scientist Institutional Award (BWF initiative to help institutions address the shortage of physician-scientists). The Burroughs Wellcome Fund is offering a second round of the Physician-Scientist Institutional Awards (PSIA) program that was instituted in 2017 to increase the number of single degree M.D.’s who enter research. The PSIA advisory committee will review novel and innovative proposals demonstrating how institutions will utilize a $2.5 million grant from BWF that outlines opportunities and support for the M.D. (only) to pursue training, which will enable her/him to launch and continue a successful career as an independent investigator. Ten to 12 finalists will be selected and required to come to BWF headquarters in Research Triangle Park, NC for an interview on May 16/17, 2019. Up to five awards ($2,500,000 each) will be made in this program cycle. A one-step full application submission will be utilized with proposals due February 15, 2019.
     
  • Burroughs Wellcome Fund (BWF): Preterm Birth Initiative. This initiative was created to increase the understanding of the biological mechanisms underlying parturition and spontaneous preterm birth and will provide up to USD $500,000 over a four-year period (USD $125,000 per year). The initiative is designed to stimulate both creative individual scientists and multi-investigator teams to approach the problem of preterm birth using creative basic and translation science methods. Postdoctoral fellows nearing their transition to independent investigator status through senior established investigators are encouraged to apply. Deadline for applications: December 4, 2018.
     
  • Association for Frontotemporal Degeneration (AFTD): Treat FTD Fund. The Treat FTD Fund was launched in 2016 with the Alzheimer's Drug Discovery Foundation to support clinical trials testing novel or repurposed drugs for FTD disorders. Running clinical trials in FTD patients will enable investigators to identify optimal approaches to targeting this unique patient population. In addition, trials supported through the Treat FTD Fund will complement efforts such as the FTD Biomarkers initiative and the Accelerating Drug Discovery for FTD program by employing emergent advances in biomarker development and preclinical research. The targeted population should include both genetic and sporadic forms of any FTD disorder. Applications must include a clear description of the rationale for the mechanism of action in the targeted population. Budgets can be flexible and in the range of USD $500K to $2M for trials ranging from 1 - 3 years. Leveraging other sources of funding or other ongoing trials is encouraged. Partnerships /co-funding with industry or other foundations is acceptable. Deadline for Letters of Intent: November 9, 2018; Full application deadline: February 15, 2019.
  • Muscular Dystrophy Association (MDA): Translational Research. MVP funds projects from proof-of-principle studies through phase 2 trials. For-profit entities are required to contribute funds that match or exceed MDA's contribution. MDA will negotiate return on investment. Projects funded by MVP are milestone-driven projects, with funds released according to the completion of pre-agreed upon sections of the project. MVP will consider funding projects up to USD $1M, depending on the stage of research. MVP is interested in partnering with applicants to accelerate research on projects with strong institutional support, and in general MVP funds should constitute less than 50% of the total project budget. Deadline for Letters of Intent: December 1, 2018; March 1, 2019; June 1, 2019; and September 1, 2019.

  • Rally Foundation for Childhood Cancer Research: Collaborative Pediatric Cancer Research Awards Program. Rally funds research in the following areas: 
    - Under-studied cancer types 
    - Innovative approaches to childhood cancer research which could lead to advanced studies or clinical trials 
    - Studies that are likely to lead to a clinical trial, personalized, alternative, or integrated research proposals 
    - Quality of life and survivorship research proposals 
    Award categories include: Fellowship Grants; Investigator and Independent Investigator Research Grants; and Consortium Grants. Deadline for Letters of Intent: December 11, 2018; Full application deadline: January 11, 2019.
     

 

Back to Top